HONG KONG – The China National Drug Administration (CNDA) has approved the first domestically developed HIV drug. Known as Aikening (albuvirtide for injection), the novel drug was developed by Frontier Biotechnologies Inc., of Nanjing, to treat HIV-1 infection. Read More
PERTH, Australia – Mesoblast Ltd. has signed a deal with China's Tasly Pharmaceutical Group that opens up the massive greater China market to the Aussie stem cell company to develop, manufacture and commercialize two of its late-stage allogeneic mesenchymal precursor cell (MPC) candidates for cardiovascular indications. Read More
HONG KONG – Changchun Changsheng Life Sciences Ltd., China's second largest rabies vaccine producer, was ordered to stop production and recall batches of its rabies vaccines after the China National Drug Administration (CNDA) reportedly uncovered falsified data and inspection records. Read More
TAIPEI, Taiwan – Precision medicine was a big topic at BioTaiwan, with one very local case study highlighting the promise of both the evolving field, as well as Taiwan's role as a clinical research location – a role the government is seeking to expand. Read More
HONG KONG – In the wake of a canceled anti-monopoly probe, Chinese drugmaker Hainan Haiyao Co. Ltd. plans to acquire Haikou Qili Pharmacy Co. Ltd. for ¥2.142 billion (US$322 million). Read More
Beigene Ltd., of Beigene, China, said it attended a hearing before the listing committee of the Stock Exchange of Hong Kong Ltd. (HKEX) in connection with its application to list its ordinary shares on the main board of HKEX. Read More
Cstone Pharmaceuticals Co. Ltd., of Sozhou, China, appointed Richard Yeh chief financial officer. Yeh has over 20 years of experience working for investment banks and multinational biopharmaceutical companies. Read More
